bodyType

customContents

entityId

entityUuid

articlePageQuery

filter

article

articleBaseAdvertisingInfoArticle

articleListArticle

articleSeoArticle

hooksArticleAcknowledgementGateOverlayArticle

hooksTrackPageViewArticle

hooksContentInterestArticle

articleLinkingDataContent

hooksAmpRedirectArticle

articleSchemaContent

liveArticle

advertZone

sentiment

contentLock

topics

types

sections

paywallTypes

createdDate

publishedDate

sponsorType

urlAlias

moreOnThisArticles

commentCount

authorLocations

authors

corrections

displaySlideShow

multimediaEmbed

printHeadline

seriesContainer

articleSpeeches

socialHeadline

headline

images

flag

firstTopic

glossary

flattenTypeIds

image

relatedLinks

relatedNewsletters

__typename

sponsor

pdfFiles

seriesReverseOrder

series

disableOffPlatformContent

published

updatedDate

summary

subHeadline

body

keywords

readingTime

customTimezone

liveContents

How mono or ‘the kissing disease’ may increase your risk for other illnesses

Former British finance minister defects to Reform UK, backing Farage for PM

Trump-Xi diplomacy put to test thanks to tit-for-tat Covid lawsuits

Mistrial in case of ex-top aide to New York governor charged with working as China agent

Coronavirus pandemic: All stories

India Covid-19 crisis’ impact on Indian and Chinese economies

Coronavirus

Apple’s attempt to diversify manufacturing to India is being stymied by New Delhi’s coronavirus crisis

India’s ambitions to become the “new China” in phone manufacturing are now being blunted by one of the world’s worst outbreaks of Covid-19. Photo: Reuters

FILE PHOTO: The lobby of Foxconn's office in Taipei, Taiwan, June 23, 2020. REUTERS/Ann Wang/File Photo

India’s plan to become a smartphone manufacturing superpower is being thwarted by its Covid-19 crisis and problems could linger, putting China back in the frame, analysts say.


India’s medicine makers in logistical ‘mess’ as coronavirus crisis disrupts pharmaceutical supply chain

Nearly a third of all Indian factories that make active pharmaceutical ingredients are located in areas that were recently placed under pandemic-forced lockdowns, and many workers have fallen ill. Illustration: Brian Wang

World’s largest provider of generic drugs is seeing its pharmaceutical companies stagger shifts as Indian workers fall ill and shipments of crucial supplies from China are delayed.


India’s coronavirus crisis threatens plans for post-pandemic supply chain shift from China

India’s second coronavirus wave is threatening to put many small exporters out of business and slow the country’s economic recovery. Illustration: Brian Wang

India’s second wave is threatening to put some small exporters out of business, slow the country’s economic recovery and set back attempts to capitalise on supply chain shifts from China.


Indian seafarers left in limbo as coronavirus restrictions create chaos in shipping industry

Illustration: Ka-kuen Lau

FILE PHOTO: Container ships are loaded at a container terminal in the harbor amid the outbreak of coronavirus disease (COVID-19) in Hamburg, Germany, March 29, 2021. REUTERS/Fabian Bimmer/File Photo

OAKLAND, CALIFORNIA - MAY 07: In an aerial view, an APL container ship pulls into the Port of Oakland on May 07, 2021 in Oakland, California. The Port of Oakland reported a record high in cargo traffic volume between January and March of this year with 631,119 20-foot shipping containers compared to 612,151 set in the first quarter of 2019. Justin Sullivan/Getty Images/AFP == FOR NEWSPAPERS, INTERNET, TELCOS & TELEVISION USE ONLY ==

FILE- In this Jan. 21, 2021, file photo, employees pack boxes containing vials of Covishield, a version of the AstraZeneca vaccine at the Serum Institute of India in Pune, India. India, the world’s largest maker of vaccines, was expected to play a pivotal role in global efforts to immunize against COVID-19. But its own capacity is proving to be insufficient for its own massive needs amid a ferocious surge of new infections. In past weeks, many people wanting to get vaccines have been turned away. Experts say that this is due to bad planning. (AP Photo/Rafiq Maqbool, File)

Difficulties securing vaccines mean seafarers face job losses as well as obstacles to returning home after finishing contracts.


This is a series of stories about the impact of India’s Covid-19 crisis on the Indian and Chinese economies and the global initiative to restructure supply chains.


India Covid-19 crisis’ impact on Indian and Chinese economies

This is a series of stories about the impact of India’s Covid-19 crisis on the Indian and Chinese economies and the global initiative to restructure supply chains.

Apple’s India plans swamped by country’s coronavirus crisis

India’s plan to become a smartphone manufacturing superpower is being thwarted by its Covid-19 crisis and problems could linger, putting China back in the frame, analysts say.

India’s medicine makers in ‘mess’ as coronavirus hits supply chain

World’s largest provider of generic drugs is seeing its pharmaceutical companies stagger shifts as Indian workers fall ill and shipments of crucial supplies from China are delayed.

India’s Covid-19 crisis puts pressure on supply chain shift from China

India’s second wave is threatening to put some small exporters out of business, slow the country’s economic recovery and set back attempts to capitalise on supply chain shifts from China.

Indian seafarers left in limbo due to tighter Covid-19 restrictions

Difficulties securing vaccines mean seafarers face job losses as well as obstacles to returning home after finishing contracts.